TruScreen appoints AIR for South African distribution

TruScreen has announced the appointment of AIR as the distributor for its AI-enabled cervical cancer screening system in South Africa.

The decision to enter the South African market is significant, given the country's high cervical cancer mortality rate of 19.6 per 100,000, compared to 1.7 per 100,000 in New Zealand and Australia.

South Africa also had the 10th highest global cervical cancer incidence in 2022.

TruScreen's portable, real-time and laboratory-free screening system is seen as a solution to the challenges of late diagnosis, limited screening coverage and healthcare access in the country.

AIR, a South African medical products company, will be responsible for marketing and selling TruScreen in South Africa, with support from Evohealth, a Gauteng-based manufacturer and distributor.

The registration process is expected to be completed in three months, with the first sales anticipated in January 2026.

This development expands TruScreen's African distribution reach to an addressable market of 30 million women.